Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
23 | Antibiotics | journal | 0.121 Q3 | 77 | 5 | 1 | 133 | 0 | 1 | 0.00 | 26.60 | 31.25 | |
22 | Pharmacoeconomics - Spanish Research Articles | journal | 0.127 Q3 | 6 | 15 | 43 | 463 | 10 | 36 | 0.26 | 30.87 | 29.17 | |
21 | Developments in Biologicals | journal | 0.144 Q4 | 41 | 20 | 1 | 0 | 1 | 1 | 1.00 | 0.00 | 37.50 | |
20 | Botulinum Journal | journal | 0.215 Q2 | 6 | 10 | 23 | 188 | 16 | 20 | 0.80 | 18.80 | 37.50 | |
19 | Modern Trends in Pharmacopsychiatry | journal | 0.229 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
18 | International Journal of Biomedical Nanoscience and Nanotechnology | journal | 0.388 Q2 | 9 | 7 | 25 | 387 | 26 | 25 | 1.04 | 55.29 | 28.57 | |
17 | Pharmaceutics | journal | 0.426 Q2 | 106 | 37 | 79 | 1934 | 107 | 78 | 1.38 | 52.27 | 42.14 | |
16 | Scientia Pharmaceutica | journal | 0.515 Q2 | 54 | 75 | 177 | 1970 | 305 | 172 | 1.61 | 26.27 | 28.68 | |
15 | Inflammopharmacology | journal | 0.529 Q3 | 68 | 36 | 98 | 2083 | 249 | 95 | 1.82 | 57.86 | 41.28 | |
14 | Pharmaceuticals | journal | 0.539 Q2 | 87 | 78 | 297 | 5945 | 500 | 293 | 1.70 | 76.22 | 35.85 | |
13 | Pharmacology | journal | 0.540 Q2 | 67 | 89 | 290 | 2925 | 545 | 266 | 2.07 | 32.87 | 39.70 | |
12 | Frontiers in Pharmacology | journal | 0.717 Q2 | 154 | 206 | 129 | 17703 | 312 | 125 | 2.42 | 85.94 | 41.23 | |
11 | Toxins | journal | 0.731 Q2 | 116 | 89 | 259 | 6168 | 651 | 257 | 2.56 | 69.30 | 44.30 | |
10 | Chemotherapy | journal | 0.735 Q2 | 61 | 61 | 186 | 2084 | 446 | 181 | 2.51 | 34.16 | 30.75 | |
9 | Molecules | journal | 0.792 Q1 | 227 | 1056 | 1811 | 41682 | 5832 | 1809 | 2.93 | 39.47 | 40.04 | |
8 | AAPS PharmSciTech | journal | 0.804 Q1 | 116 | 164 | 529 | 5176 | 1260 | 529 | 2.16 | 31.56 | 35.23 | |
7 | Inflammation Research | journal | 0.806 Q2 | 107 | 157 | 443 | 6226 | 997 | 440 | 2.13 | 39.66 | 39.65 | |
6 | Molecular Diversity | journal | 0.852 Q2 | 63 | 76 | 234 | 2527 | 780 | 225 | 3.10 | 33.25 | 30.16 | |
5 | Marine Drugs | journal | 0.897 Q2 | 159 | 195 | 377 | 8688 | 1775 | 376 | 4.85 | 44.55 | 40.89 | |
4 | Skin Pharmacology and Physiology | journal | 1.116 Q1 | 86 | 43 | 143 | 1575 | 463 | 133 | 3.07 | 36.63 | 47.37 | |
3 | Progress in Drug Research | book series | 3.084 Q1 | 46 | 0 | 15 | 0 | 92 | 13 | 6.13 | 0.00 | 0.00 | |
2 | Cellular and Molecular Life Sciences | journal | 3.403 Q1 | 261 | 293 | 899 | 30443 | 6406 | 889 | 6.46 | 103.90 | 36.92 | |
1 | Antibodies | journal | 42 | 17 | 0 | 1370 | 0 | 0 | 0.00 | 80.59 | 36.51 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®